A, TTP expression analyzed by immunoblotting of whole cell lysates of EG7 TAMs and resting or LPS treated BMDMs. Blots were re-probed using anti-GRB2 antibody to confirm equal loading and represent 1 out of 3 experiments. B, TNF mRNA stability determined by qRT-PCR by comparing cells before and 90 minutes after transcriptional blockade by Actinomycin D in BMDMs and TAMs isolated from EG7 thymomas (T-TAM), neuroblastomas (N-TAM) or osteosarcomas (O-TAM). Values were normalized to GAPDH and represent % TNF mRNA remaining after Actinomycin D treatment as mean and SEM of at least 2 experiments (n ≥ 2). C, immunoblot analysis of total cell lysates of non-stimulated (ns) or 1hr LPS stimulated (LPS) BMDMs as well as TAMs isolated from different tumor models as in B, probed with anti-phospho-p38, anti-p38 or anti-GRB2 as loading control. The blot represents 1 out of 3 experiments. D, p38 phosphorylation analyzed by immunoblotting of whole EG7 TAM lysates from WT TAMs directly after isolation (−) or after resting them on tissue culture dishes (TC) for 3 hrs. E and F, immunoblot analysis of whole EG7 TAM lysates (E) or BMDMs left untreated or stimulated with LPS for 1 and 3 hrs (F) isolated from WT or p38αΔM animals. Blots represent 1 out of 2 experiments. G, Whole EG7 TAM lysates from WT or p38αΔH animals as in (E) analyzed for p38 and p-p38 protein expression by immunoblotting (n = 2). H, flow cytometry analysis of p-p38 in CD11b+ EG7 TAMs isolated from WT or p38αΔH animals (n ≥ 4). Representative plots are shown with unstained control as grey line.